TBPH Operating Cash Flow (Statement)
Theravance Biopharma Inc · Operating Cash Flow (Statement)
TBPH Operating Cash Flow (Statement)
Latest reported$51.83Mperiod ending
TBPH TTM Cash from Operations (-$120.96M → $51.83M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TBPH operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 51,826,000 | |
| 268,781,000 | |
| 238,541,000 | |
| 243,703,000 | |
| 245,015,000 | |
| 32,526,000 | |
| -11,535,000 | |
| -11,487,000 | |
| -8,777,000 | |
| -16,798,000 | |
| -26,997,000 | |
| -150,198,000 | |
| -169,849,000 | |
| -172,143,000 | |
| -186,991,000 | |
| -105,370,000 | |
| -128,679,000 | |
| -164,062,000 | |
| -207,858,000 | |
| -230,349,000 | |
| -261,934,000 | |
| -265,167,000 | |
| -250,403,000 | |
| -249,830,000 | |
| -217,421,000 | |
| -212,105,000 | |
| -238,197,000 | |
| -226,023,000 | |
| -230,378,000 | |
| -243,885,000 | |
| -112,867,000 | |
| -104,891,000 | |
| -118,213,000 | |
| -101,201,000 | |
| -201,052,000 | |
| -184,963,000 | |
| -135,096,000 | |
| -122,706,000 | |
| -98,989,000 | |
| -104,622,000 | |
| -124,173,000 | |
| -138,652,000 | |
| -168,857,000 | |
| -177,650,000 | |
| -182,044,000 | |
| -186,870,000 | |
| -175,155,000 | |
| -167,804,000 | |
| -164,362,000 | |
| -137,267,000 | |
| -120,959,000 | |
| -108,478,000 | |
| -100,358,000 |